# HealthCare Ventures: portfolio, investments and team

> HealthCare Ventures is a growth equity based in United States. 70 investments on record, latest Sept 2015. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/healthcare-ventures-llc (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# HealthCare Ventures

No cheque observed since Sep 2015, after 70 earlier cheques, and the website is dead.

Dormant New fund $7.2M, Jun 2019 Growth equity

Series B Series C Series A Healthcare Home Services Recruiting

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 70 on record

Since the last cheque **4067** days **00** hrs **00** min **00** sec

Median round **$21M** Rounds led **0 of 70** Sole investor **2 rounds** Exits **11 from the portfolio** Mostly in **United States, 97%**

Pitch HealthCare Ventures

## HealthCare Ventures highlights

- 01 70 rounds on record
- 02 Mostly Series B and Series C: 55% of its rounds
- 03 Sole investor in 2 rounds, median $8.0M
- 04 11 exits from the portfolio

## What they do

- **Type:** Growth equity (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Healthcare Home Services Recruiting
- **Based in:** Princeton, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **70 appearances**

- **2015** 1 round
- **Sept** **[Proteostasis Therapeutics](https://millionrounds.com/company/proteostasis-therapeutics)** Series B · US **$37M** With 7 others
- **2014** 1 round
- **Jun** **[Senseonics](https://millionrounds.com/company/senseonics)** Venture · US **$20M** With 4 others
- **2013** 4 rounds
- **Oct** **[Pathogenetix](https://millionrounds.com/company/pathogenetix)** Series C · US · finsmes.com **$10M** With 2 others
- **Apr** **[Catalyst Biosciences](https://millionrounds.com/company/catalyst-biosciences)** Venture · US **$5.1M** With 5 others
- **Mar** **[Theraclone Sciences](https://millionrounds.com/company/theraclone-sciences)** Series B · US · finsmes.com **$8.0M** With 7 others
- **Feb** **[DecImmune Therapeutics](https://millionrounds.com/company/decimmune-therapeutics)** Growth · US · finsmes.com **$2.3M** With 2 others
- **2012** 3 rounds
- **Jun** **[GITR](https://millionrounds.com/company/gitr)** Venture · US · masshightech.com **$1.0M** Sole investor
- **Mar** **[Promedior](https://millionrounds.com/company/promedior)** Series D · US · fiercebiotech.com **$22M** With 5 others
- **Feb** **[Radius Health](https://millionrounds.com/company/radius-health)** Series C · US · onbiovc.com **$21M** With 6 others
- **2011** 11 rounds
- **Dec** **[Radius Health](https://millionrounds.com/company/radius-health)** Growth · US **$21M** With 6 others
- **Nov** **[Mosaic Biosciences](https://millionrounds.com/company/mosaic-biosciences)** Series A · US · onbiovc.com **$1.0M** With 2 others
- **Nov** **[Sensors for Medicine and Science](https://millionrounds.com/company/sensors-for-medicine-and-science)** Series D · US · pr-inside.com **$54M** With 4 others
- **Nov** **[Pathogenetix](https://millionrounds.com/company/pathogenetix)** Series B · US · masshightech.com **$7.5M** With 3 others
- **Sept** **[Tensha Therapeutics](https://millionrounds.com/company/tensha-therapeutics)** Series A · US · finsmes.com **$15M** Sole investor
- **Aug** **[Cleveland HeartLab](https://millionrounds.com/company/cleveland-heartlab)** Series B · US · finsmes.com **$18M** With 1 other
- **Aug** **[Pathogenetix](https://millionrounds.com/company/pathogenetix)** Series B · US · pathogenetix.com **$4.0M** With 2 others
- **Jul** **[Radius Health](https://millionrounds.com/company/radius-health)** Series C · US · onbiovc.com **$66M** With 6 others
- **Jul** **[nanoMR](https://millionrounds.com/company/nanomr)** Series B · US · nanomr.com **$13M** With 3 others
- **Jun** **[Stemgent](https://millionrounds.com/company/stemgent)** Series B · US · sec.gov **$11M** With 1 other
- **Feb** **[CellNovo](https://millionrounds.com/company/cellnovo)** Series B · GB · cellnovo.com **$48M** With 8 others
- **2010** 8 rounds
- **Oct** **[Dicerna Pharmaceuticals](https://millionrounds.com/company/dicerna-pharmaceuticals)** Series B · US · masshightech.com **$4.0M** With 1 other
- **Sept** **[DecImmune Therapeutics](https://millionrounds.com/company/decimmune-therapeutics)** Venture · US · finsmes.com **$3.2M** With 2 others
- **Aug** **[Anchor Therapeutics](https://millionrounds.com/company/anchor-therapeutics)** Series B · US · anchortx.com **$10M** With 2 others
- **Aug** **[TetraLogic Pharmaceuticals](https://millionrounds.com/company/tetralogic-pharmaceuticals)** Series C · US · fiercebiotech.com **$32M** With 7 others
- **Jul** **[Trevena](https://millionrounds.com/company/trevena)** Series B · US · onbiovc.com **$35M** With 3 others
- **Jun** **[Foldrx Pharmaceuticals](https://millionrounds.com/company/foldrx-pharmaceuticals)** Venture · US · fiercebiotech.com **$29M** With 7 others
- **Mar** **[Theraclone Sciences](https://millionrounds.com/company/theraclone-sciences)** Series B · US · xconomy.com **$1.5M** With 5 others
- **Mar** **[Seahorse Bioscience](https://millionrounds.com/company/seahorse-bioscience)** Series D · US · onbiovc.com **$5.0M** With 6 others
- **2009** 6 rounds
- **Nov** **[Stemgent](https://millionrounds.com/company/stemgent)** Debt · US · masshightech.com **$2.7M** With 1 other
- **Oct** **[Xanodyne](https://millionrounds.com/company/xanodyne)** Series D · US **$88M** With 6 others
- **Jul** **[PharmAthene](https://millionrounds.com/company/pharmathene)** Secondary · US · ir.pharmathene.com **$19M** With 3 others
- **Jun** **[Xanodyne](https://millionrounds.com/company/xanodyne)** Series D · US · onbiovc.com **$38M** With 6 others
- **Jun** **[VaxInnate](https://millionrounds.com/company/vaxinnate)** Series D · US · onbiovc.com **$30M** With 6 others
- **Mar** **[Seahorse Bioscience](https://millionrounds.com/company/seahorse-bioscience)** Series D · US · masshightech.com **$6.0M** With 6 others
- **2008** 4 rounds
- **Dec** **[Catalyst Biosciences](https://millionrounds.com/company/catalyst-biosciences)** Series C · US · fiercebiotech.com **$40M** With 6 others
- **Nov** **[Radius Health](https://millionrounds.com/company/radius-health)** Series C · US · radiuspharm.mwnewsroom.com **$15M** With 6 others
- **Aug** **[Proteostasis Therapeutics](https://millionrounds.com/company/proteostasis-therapeutics)** Series A · US · sec.gov **$71M** With 5 others
- **Mar** **[Trevena](https://millionrounds.com/company/trevena)** Series A · US · trevenainc.com **$24M** With 3 others
- **2007** 8 rounds
- **Nov** **[Ascent Therapeutics](https://millionrounds.com/company/ascent-therapeutics)** Series A · US · venturedeal.com **$19M** With 3 others
- **Nov** **[BIKAM Pharmaceuticals](https://millionrounds.com/company/bikam-pharmaceuticals)** Series A **$11M** With 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **5 named**

DP **David Paltzik** Promoter i Filing they signed

HR **Harold Robert Werner** Member i Form ADV

JH **James Henry Cavanaugh** Member i Form ADV

JW **John Walter Littlechild** Member i Form ADV

MK **Marla Kay Mcmillan** Vice President of Finance i Form ADV

We also hold **10** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$5.1M** gross assets of its funds Oct 2026

**Exempt** reporting adviser venture or small private funds

- **Legal name:** HCV Management VIII, LLC
- **SEC number:** CRD 163510

## Exits from the portfolio

Companies it backed that were later bought or listed **11 in all**

**[Seahorse Bioscience](https://millionrounds.com/company/seahorse-bioscience)** Bought by [Agilent Technologies](https://millionrounds.com/fund/agilent-technologies) **$235M** Sept 2015

**[RedPath Integrated Pathology](https://millionrounds.com/company/redpath-integrated-pathology)** Bought by PDI,Inc. **Undisclosed** Nov 2014

**[SkinMedica](https://millionrounds.com/company/skinmedica)** Bought by [Allergan](https://millionrounds.com/fund/allergan) **Undisclosed** Nov 2012

**[Cardiokine](https://millionrounds.com/company/cardiokine)** Bought by Cornerstone Therapeutics **Undisclosed** Jan 2012

**[Foldrx Pharmaceuticals](https://millionrounds.com/company/foldrx-pharmaceuticals)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Sept 2010

**[RedPath Integrated Pathology](https://millionrounds.com/company/redpath-integrated-pathology)** Bought by ExonHit Therapeutics **$32M** Apr 2010

**[BioProcessors](https://millionrounds.com/company/bioprocessors)** Bought by Seahorse Bioscience **Undisclosed** Mar 2009

**[Replidyne](https://millionrounds.com/company/replidyne)** Bought by [Cardiovascular Systems](https://millionrounds.com/fund/cardiovascular-systems) **Undisclosed** Feb 2009

**[Avidia](https://millionrounds.com/company/avidia)** Bought by [Amgen](https://millionrounds.com/fund/amgen) **$290M** Sept 2008

**[Xanthus Pharmaceuticals](https://millionrounds.com/company/xanthus-pharmaceuticals)** Bought by Antisoma **Undisclosed** May 2008

**[Critical Therapeutics,Inc.](https://millionrounds.com/company/critical-therapeutics-inc)** Bought by Cornerstone Therapeutics **Undisclosed** May 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

New fund on file

**$7.2M**

raised in Jun 2019

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Series B Series C Series A

Median round joined **$21M** the round, not its cheque Alone, median **$8.0M**

Led 0 of 70 rounds **0%**

- **Sole investor:** 2 rounds
- **Last cheque:** Sept 2015
- **Exits:** 11 from the portfolio

Rounds by stage said on their site

- Series B *22*
- Series C *14*
- Series A *12*
- Series D *10*
- Venture *5*
- Growth *3*

Cheques by year Led Joined

2001 2015

Often in the room with

- [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact) 13
- [Morgenthaler Ventures](https://millionrounds.com/fund/morgenthaler) 12
- [Oxford Bioscience Partners](https://millionrounds.com/fund/oxford-bioscience-partners) 11
- [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) 8
- [Wellcome Trust](https://millionrounds.com/fund/wellcome-trust) 8
- [Johnson & Johnson Development Corporation (JJDC)](https://millionrounds.com/fund/johnson-and-johnson-development-corporation) 7

**Pitching HealthCare Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as HealthCare Ventures. A count of rooms they were both in, not a relationship either has claimed.

[**MPM Capital** Private equity **13** rounds together](https://millionrounds.com/fund/mpm-bioimpact)[**Morgenthaler Ventures** VC firm **12** rounds together](https://millionrounds.com/fund/morgenthaler)[**Oxford Bioscience Partners** Growth equity **11** rounds together](https://millionrounds.com/fund/oxford-bioscience-partners)[**Novartis Venture Fund** Corporate VC **8** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**Wellcome Trust** Government **8** rounds together](https://millionrounds.com/fund/wellcome-trust)[**Johnson & Johnson Development Corporation (JJDC)** VC firm **7** rounds together](https://millionrounds.com/fund/johnson-and-johnson-development-corporation)[**New Enterprise Associates** VC firm **7** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Rho Capital Partners** Private equity **7** rounds together](https://millionrounds.com/fund/rho-capital-partners)[**Essex Woodlands Healthcare Partners** VC firm **6** rounds together](https://millionrounds.com/fund/essex-woodlands-health-ventures)[**MedImmune Ventures** Corporate VC **6** rounds together](https://millionrounds.com/fund/medimmune-ventures)[**Amgen** Corporate VC **5** rounds together](https://millionrounds.com/fund/amgen)[**BB Biotech Ventures** Growth equity **5** rounds together](https://millionrounds.com/fund/bb-biotech-ventures)

## Quick answers about HealthCare Ventures

### What does HealthCare Ventures invest in?

HealthCare Ventures invests most often at Series B and Series C (55% of the rounds on record), in sectors such as Healthcare, Home Services and Recruiting.

### How active is HealthCare Ventures?

70 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2015.

### How big are HealthCare Ventures's cheques?

The median round it joins is $21M.

### Does HealthCare Ventures lead rounds?

Rarely, if at all: none of its 70 investments on record names it as the lead.

### Where does HealthCare Ventures invest?

Most of the companies it backs are in the United States (97%).

### Is HealthCare Ventures investing now?

It looks quiet: no investment on record since Sept 2015.

### Who does HealthCare Ventures invest alongside?

Most often MPM Capital (13 rounds together), Morgenthaler Ventures (12 rounds together) and Oxford Bioscience Partners (11 rounds together).

### What kind of investor is HealthCare Ventures?

HealthCare Ventures is a growth equity firm based in Princeton, United States.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=healthcare-ventures-llc) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=healthcare-ventures-llc)